Colorectal Cancer Surgical Emergencies in Patients with Inflammatory Bowel Disease

  • Niccolò Petrucciani
  • Nicola de’Angelis
  • Federica Gaiani
  • Francesco BrunettiEmail author
Part of the Hot Topics in Acute Care Surgery and Trauma book series (HTACST)


Inflammatory bowel diseases (IBDs) represent a well-known risk factor for the development of colorectal cancer. Even if screening programs are available for patients with IBDs to allow early detection of dysplastic and tumoral lesions, non-observant patients or those with no previous diagnosis of IBD may present with complex clinical scenarios of complicated colorectal cancer on IBD and may require emergency surgical treatment. The extent of the colitis, the gender (relative risk higher in males), the severity of inflammation (histological activity of the disease), a family history of sporadic colorectal cancer, and coexistent primary sclerosing cholangitis are risk factors for CRC in patients with IBDs. Complications of CRC requiring emergency management in patients with IBDs include bowel obstruction, colic perforation, or lower gastrointestinal bleeding. The emergency treatment of complications of CRC on IBD has three main objectives: treatment of the emergency condition, which may impact short-term prognosis, treatment of CRC, and management of IBD. The aim of this chapter is to discuss the incidence on colorectal cancer in IBDs patients, to examine the potential causes of emergency colorectal surgery in this setting, and to discuss treatment strategies in the light of the recent literature.


Colorectal cancer Inflammatory bowel disease Complications Surgical emergency Laparoscopy 


  1. 1.
    Huang LC, Merchea A. Dysplasia and cancer in inflammatory bowel disease. Surg Clin North Am. 2017;97:627–39.CrossRefGoogle Scholar
  2. 2.
    Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872–81.CrossRefGoogle Scholar
  3. 3.
    Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.CrossRefGoogle Scholar
  4. 4.
    Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.CrossRefGoogle Scholar
  5. 5.
    Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, Krieglstein CF, Senninger N, Anthoni C, Bruewer M. Intestinal cancer risk in Crohn’s disease: a meta-analysis. J Gastrointest Surg. 2011;15:576–83.CrossRefGoogle Scholar
  6. 6.
    Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–45.CrossRefGoogle Scholar
  7. 7.
    Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.CrossRefGoogle Scholar
  8. 8.
    Selinger CP, Andrews JM, Titman A, et al., Sydney IBD Cohort Study Group. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:644–50.Google Scholar
  9. 9.
    Castaño-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–59.CrossRefGoogle Scholar
  10. 10.
    Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol. 2012;18:3839–48.CrossRefGoogle Scholar
  11. 11.
    ECCO Guidelines. Inflammatory bowel disease. Accessed 25 Apr 2018.
  12. 12.
    Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2017;9:CD000279. doi:
  13. 13.
    Annese V, Daperno M, Rutter MD, et al., European Crohn’s and Colitis Organisation. European evidence-based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018.Google Scholar
  14. 14.
    Magro F, Langner C, Driessen A, et al., European Society of Pathology [ESP]; European Crohn’s and Colitis Organisation [ECCO]. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–51.CrossRefGoogle Scholar
  15. 15.
    Smida M, Miloudi N, Hefaiedh R, Zaibi R. Emergency surgery for Crohn’s disease. Tunis Med. 2016;94(3):210–5.PubMedGoogle Scholar
  16. 16.
    Kosmidis C, Anthimidis G. Emergency and elective surgery for small bowel Crohn’s disease. Tech Coloproctol. 2011;15(Suppl 1):S1–4.CrossRefGoogle Scholar
  17. 17.
    Toh JWT, Wang N, Young CJ, Rickard MJFX, Keshava A, Stewart P, Kariyawasam V, Leong R, the Sydney IBD Cohort Collaborators. Major abdominal and perianal surgery in Crohn’s disease: long-term follow-up of Australian patients with Crohn’s disease. Dis Colon Rectum. 2018;61:67–76.CrossRefGoogle Scholar
  18. 18.
    Chan WPW, Mourad F, Leong RW. Crohn’s disease associated strictures. J Gastroenterol Hepatol. 2018;33:998–1008.CrossRefGoogle Scholar
  19. 19.
    Kinugasa T, Akagi Y. Status of colitis-associated cancer in ulcerative colitis. World J Gastrointest Oncol. 2016;8:351–7.CrossRefGoogle Scholar
  20. 20.
    Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20:16389–97.CrossRefGoogle Scholar
  21. 21.
    Patel SS, Patel MS, Goldfarb M, et al. Elective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis. Am J Surg. 2013;205:333–7.CrossRefGoogle Scholar
  22. 22.
    Berg DF, Bahadursingh AM, Kaminski DL, Longo WE. Acute surgical emergencies in inflammatory bowel disease. Am J Surg. 2002;184:45–51.CrossRefGoogle Scholar
  23. 23.
    Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Greenstein AJ. Malignant strictures in Crohn’s disease. Am J Gastroenterol. 1991;86:882–5.PubMedGoogle Scholar
  24. 24.
    van Hooft JE, van Halsema EE, Vanbiervliet G, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Gastrointest Endosc. 2014;80:747–61.e1–75.CrossRefGoogle Scholar
  25. 25.
    Winner M, Mooney SJ, Hershman DL, et al. Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study. Dis Colon Rectum. 2013;56:834–43.CrossRefGoogle Scholar
  26. 26.
    Werbin N, Haddad R, Greenberg R, Karin E, Skornick Y. Free perforation in Crohn’s disease. Isr Med Assoc J. 2003;5:175–7.PubMedGoogle Scholar
  27. 27.
    Roy MK, Delicata RJ, Carey PD. Crohn’s disease presenting with acute colonic perforation. Postgrad Med J. 1997;73:645–6.CrossRefGoogle Scholar
  28. 28.
    Fraschini A, Sella D, Gullotta R, et al. Free perforation due to colonic adenocarcinoma in Crohn’s disease. Ital J Surg Sci. 1989;19:85–8.PubMedGoogle Scholar
  29. 29.
    Greenstein AJ, Gennuso R, Sachar DB, Aufses AH Jr. Free perforation due to cancer in Crohn’s disease. Int J Colorectal Dis. 1987;2:201–2.CrossRefGoogle Scholar
  30. 30.
    Ikeuchi H, Yamamura T. Free perforation in Crohn’s disease: review of the Japanese literature. J Gastroenterol. 2002;37:1020–7.CrossRefGoogle Scholar
  31. 31.
    Kim KJ, Han BJ, Yang SK, et al. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn’s disease. Dig Liver Dis. 2012;44:723–8.CrossRefGoogle Scholar
  32. 32.
    Driver CP, Anderson DN, Keenan RA. Massive intestinal bleeding in association with Crohn’s disease. J R Coll Surg Edinb. 1996;41:152–4.PubMedGoogle Scholar
  33. 33.
    Kiran RP, Nisar PJ, Goldblum JR. Dysplasia associated with Crohn’s colitis: segmental colectomy or more extended resection? Ann Surg. 2012;256:221–6.CrossRefGoogle Scholar
  34. 34.
    Maser EA, Sachar DB, Kruse D, Harpaz N, Ullman T, Bauer JJ. High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn’s colitis. Inflamm Bowel Dis. 2013;19:1827–32.PubMedGoogle Scholar
  35. 35.
    Strong S, Steele SR, Boutrous M, et al. Clinical practice guideline for the surgical management of Crohn’s disease. Dis Colon Rectum. 2015;58:1021–36.CrossRefGoogle Scholar
  36. 36.
    von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.CrossRefGoogle Scholar
  37. 37.
    Bellolio F, Cohen Z, Macrae HM, et al. Outcomes following surgery for perforating Crohn’s disease. Br J Surg. 2013;100:1344–8.CrossRefGoogle Scholar
  38. 38.
    Martin ST, Vogel JD. Restorative procedures in colonic Crohn disease. Clin Colon Rectal Surg. 2013;26:100–5.CrossRefGoogle Scholar
  39. 39.
    Ross H, Steele SR, Varma M, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2014;57:5–22.CrossRefGoogle Scholar
  40. 40.
    Maggiori L, Khayat A, Treton X, Bouhnik Y, Vicaut E, Panis Y. Laparoscopic approach for inflammatory bowel disease is a real alternative to open surgery: an experience with 574 consecutive patients. Ann Surg. 2014;260:305–10.CrossRefGoogle Scholar
  41. 41.
    Dasari BV, McKay D, Gardiner K, et al. Laparoscopic versus Open surgery for small bowel Crohn’s disease. Cochrane Database Syst Rev. 2011;(1):CD006956.Google Scholar
  42. 42.
    Wu XJ, He XS, Zhou XY, Ke J, Lan P. The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis. Int J Colorectal Dis. 2010;25:949–57.CrossRefGoogle Scholar
  43. 43.
    Chand M, Siddiqui MR, Gupta A, et al. Systematic review of emergent laparoscopic colorectal surgery for benign and malignant disease. World J Gastroenterol. 2014;20:16956–63.CrossRefGoogle Scholar
  44. 44.
    Vallance AE, Keller DS, Hill J, et al. Role of emergency laparoscopic colectomy for colorectal cancer: a population-based study in England. Ann Surg. 2018.
  45. 45.
    Holder-Murray J, Marsicovetere P, Holubar SD. Minimally invasive surgery for inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1443–58.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Leowardi C, Schneider ML, Hinz U, et al. Prognosis of ulcerative colitis-associated colorectal carcinoma compared to sporadic colorectal carcinoma: a matched pair analysis. Ann Surg Oncol. 2016;23:870–6.CrossRefGoogle Scholar
  47. 47.
    Ording AG, Horváth-Puhó E, Erichsen R, et al. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease: a nationwide population-based cohort study. Inflamm Bowel Dis. 2013;19:800–5.CrossRefGoogle Scholar
  48. 48.
    Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802–8.CrossRefGoogle Scholar
  49. 49.
    Reynolds IS, O’Toole A, Deasy J, McNamara DA, Burke JP. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer. Int J Colorectal Dis. 2017;32:443–51.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Niccolò Petrucciani
    • 1
    • 2
  • Nicola de’Angelis
    • 3
    • 2
  • Federica Gaiani
    • 4
  • Francesco Brunetti
    • 3
    Email author
  1. 1.Service of Digestive, Hepato-Pancreato-Biliary Surgery and Liver TransplantationHenri Mondor Hospital, AP-HPCreteilFrance
  2. 2.University of Paris Est, UPECCreteilFrance
  3. 3.Service of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Unit of Minimally Invasive and Robotic SurgeryHenri Mondor Hospital, AP-HPCréteilFrance
  4. 4.Gastroenterology and Endoscopy Unit, University Hospital of ParmaUniversity of ParmaParmaItaly

Personalised recommendations